Steven Cohen Boston Scientific Corp Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Boston Scientific Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,460,663 shares of BSX stock, worth $239 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
2,460,663
Previous 1,880,535
30.85%
Holding current value
$239 Million
Previous $190 Million
39.32%
% of portfolio
0.59%
Previous 0.47%
Shares
30 transactions
Others Institutions Holding BSX
# of Institutions
1,910Shares Held
1.27BCall Options Held
9.71MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA137MShares$13.3 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.34 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.37 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.29 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $139B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...